Federal health officials issued a warning Tuesday over misleading statements made by biotech billionaire Dr. Patrick ...
Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about ...
Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...
MedPage Today on MSN
FDA Flags Misleading Claims on Cancer Drug Made by Billionaire Owner of ImmunityBio
Patrick Soon-Shiong recently said Anktiva may be able to cure or prevent other cancers ...
COSMETIC botulinum toxin type A may trigger serum sickness, widening concern about delayed systemic hypersensitivity ...
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research sessionAcross the COAST 1, ...
MedPage Today on MSN
FDA OKs Therapy for Deadly Pediatric Immune Disorder
Kids with severe LAD-I, caused by ITGB2 mutations, are at risk of life-threatenin ...
This hematopoietic gene therapy offers a new treatment for children with severe leukocyte adhesion deficiency-I without matched transplant donors.
The FDA has granted accelerated approval to Avlayah (tividenofusp alfa-eknm) for neurologic manifestations of Hunter syndrome in pediatric patients.
Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions for two drugs for the treatment of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results